UNLIMITED TURBO SHORT - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 01:18:15 25/06/2024 am IST | ||
| 3.34 EUR | -1.47% |
|
| Current month | -2.34% | ||
| 1 month | -1.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 3.34 | -1.47% |
| 21/24/21 | 3.39 | -2.02% |
| 20/24/20 | 3.46 | +0.29% |
| 19/24/19 | 3.45 | -0.58% |
| 18/24/18 | 3.47 | +0.58% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 01:18 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PE6RD4 |
| ISIN | DE000PE6RD47 |
| Date issued | 15/12/2022 |
| Strike | 77.83 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.52 € |
|---|---|
| Lowest since issue | 0.28 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.23
USD
Average target price
53.19
USD
Spread / Average Target
+25.96%
- Stock Market
- Certificates
- Certificat
